These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23199653)

  • 21. Comparison of nodal risk formula and MR lymphography for predicting lymph node involvement in prostate cancer.
    Deserno WM; Debats OA; Rozema T; Fortuin AS; Heesakkers RA; Hoogeveen Y; Peer PG; Barentsz JO; van Lin EN
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):8-15. PubMed ID: 20800390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the lymph nodes in penile cancer.
    Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
    Lawton CA; Michalski J; El-Naqa I; Buyyounouski MK; Lee WR; Menard C; O'Meara E; Rosenthal SA; Ritter M; Seider M
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):383-7. PubMed ID: 18947938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning.
    Marnitz S; Köhler C; Schneider A; Seiler F; Hinkelbein W
    Strahlenther Onkol; 2006 Feb; 182(2):80-5. PubMed ID: 16447014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphotropic nanoparticle-enhanced MRI in prostate cancer: value and therapeutic potential.
    Fortuin AS; Smeenk RJ; Meijer HJ; Witjes AJ; Barentsz JO
    Curr Urol Rep; 2014 Mar; 15(3):389. PubMed ID: 24430170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
    Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
    N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
    Bastide C; Brenot-Rossi I; Garcia S; Rossi D
    Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.
    Turkbey B; Agarwal HK; Shih J; Bernardo M; McKinney YL; Daar D; Griffiths GL; Sankineni S; Johnson L; Grant KB; Weaver J; Rais-Bahrami S; Harisinghani M; Jacobs P; Dahut W; Merino MJ; Pinto PA; Choyke PL
    AJR Am J Roentgenol; 2015 Jul; 205(1):64-9. PubMed ID: 26102381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of lymphatic-system malformations in primary lymphoedema based on MR lymphangiography.
    Liu NF; Yan ZX; Wu XF
    Eur J Vasc Endovasc Surg; 2012 Sep; 44(3):345-9. PubMed ID: 22831870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.
    Turkbey B; Czarniecki M; Shih JH; Harmon SA; Agarwal PK; Apolo AB; Citrin DE; Gulley JL; Harisinghani M; Madan RA; Metwalli AR; Paquette E; Pinto PA; Rais-Bahrami S; Rowe LS; Wood BJ; Jacobs PM; Lindenberg L; Dahut W; Choyke PL
    AJR Am J Roentgenol; 2020 Jan; 214(1):105-113. PubMed ID: 31613660
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.
    Vargas CE; Galalae R; Demanes J; Harsolia A; Meldolesi E; Nürnberg N; Schour L; Martinez A
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1474-82. PubMed ID: 15964706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: a retrospective radiological review and implications for prostate and pelvis radiotherapy.
    Jackson AS; Sohaib SA; Staffurth JN; Huddart RA; Parker CC; Horwich A; Dearnaley DP
    Clin Oncol (R Coll Radiol); 2006 Mar; 18(2):109-16. PubMed ID: 16523810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR evaluation of normal retroperitoneal and pelvic lymph nodes.
    Grubnic S; Vinnicombe SJ; Norman AR; Husband JE
    Clin Radiol; 2002 Mar; 57(3):193-200; discussion 201-4. PubMed ID: 11952313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospectively packaged ilioinguinal lymphadenectomy for penile cancer: the disseminative pattern of lymph node metastasis.
    Zhu Y; Zhang SL; Ye DW; Yao XD; Dai B; Zhang HL; Shen YJ; Zhu YP; Shi GH; Ma CG
    J Urol; 2009 May; 181(5):2103-8. PubMed ID: 19286211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.